Aeovian Pharmaceuticals

Aeovian Pharmaceuticals Inc.

Aeovian Pharmaceuticals was founded in 2012, is headquartered in Berkeley, United States, lists 11–50 employees, and has $142.0M in recorded funding across 3 rounds.

Employees
11–50
Founded
2012
Business Model
B2B
Total Funding
$142.0M
Last Round
$55.0M Series BDec 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 1 investor for this company. The full record is or through the API.

About

Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted and highly selective small molecules to restore cellular metabolic quality control. These candidates address the dysregulated growth and hyperactive signaling found in certain rare genetic and age-related diseases. The company is focused on improving treatments in areas such as seizures, where existing mTOR inhibitors can have efficacy but also significant safety limitations.

Summary

Aeovian Pharmaceuticals is a Biotech company based in Berkeley, United States, founded in 2012. It lists 11–50 employees. It has raised $142.0M in total across 3 rounds, most recently a $55.0M Series B round in Dec 2025. Investors include LUMA.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BDec 2025
$55.0M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aeovian Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/aeovian-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/aeovian-pharmaceuticals" alt="Aeovian Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>